AI Analysis
AI-generated analysis. Always verify with the original filing.
At the Extraordinary General Meeting of Shareholders held on March 5, 2026, RedHill Biopharma Ltd. shareholders approved grants of restricted share units to non-executive directors, CEO and Chairman Dror Ben-Asher, and Chief Commercial Officer and Director Rick D. Scruggs, and an increase in the Company's authorized share capital.
Key Takeaways
1Extraordinary General Meeting held on March 5, 2026
2All proposed resolutions duly approved
3RSUs granted to non-executive directors, each RSU representing one American Depository Share (10,000 ordinary shares)
4RSUs granted to Dror Ben-Asher, Chief Executive Officer and Chairman
5RSUs granted to Rick D. Scruggs, Chief Commercial Officer and Director
6Increase in authorized share capital approved